Page 2 - சீனா தேசிய மருந்து குழு நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சீனா தேசிய மருந்து குழு நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சீனா தேசிய மருந்து குழு நிறுவனம் Today - Breaking & Trending Today

LankaWeb – Sinopharm COVID jabs rolled out among Sri Lankans from next week


Posted on May 7th, 2021
Courtesy Ada Derana
China-made Sinopharm COVID-19 vaccine will be administered to Sri Lankans starting from next week, says State Minister of Production, Supply and Regulation of Pharmaceuticals Prof. Channa Jayasumana.
The Sinopharm jabs are expected to be administered based on the coronavirus cases identified in each Grama Niladhari division, he noted.
Meanwhile, during a virtual discussion between President Gotabaya Rajapaksa and World Health Organization’s Director-General Dr. Tedros Adhanom, it transpired that approval would be given in another 2-3 days for the China-made Sinopharm coronavirus vaccine to be used for emergency use.
The National Medicines Regulatory Authority (NMRA) approved the emergency use of Sinopharm COVID-19 vaccine in Sri Lanka on March 20. ....

Sri Lanka , Sri Lankans , Tedros Adhanom , Channa Jayasumana , Ada Derana , Gotabaya Rajapaksa , China National Biotec Group , China National Pharmaceutical Group Corporation , World Health Organization , Regulation Of Pharmaceuticals Prof , National Medicines Regulatory Authority , Courtesy Ada , State Minister , Grama Niladhari , President Gotabaya Rajapaksa , China Made Sinopharm , ஸ்ரீ லங்கா , சீனா தேசிய பயோடெக் குழு , சீனா தேசிய மருந்து குழு நிறுவனம் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , ஒழுங்குமுறை ஆஃப் மருந்துகள் ப்ரொஃப் , தேசிய மருந்துகள் ஒழுங்குமுறை அதிகாரம் , மரியாதை அடா , நிலை அமைச்சர் ,

LankaWeb – Sinopharm COVID jabs rolled out among Sri Lankans from next week


Posted on May 7th, 2021
Courtesy Ada Derana
China-made Sinopharm COVID-19 vaccine will be administered to Sri Lankans starting from next week, says State Minister of Production, Supply and Regulation of Pharmaceuticals Prof. Channa Jayasumana.
The Sinopharm jabs are expected to be administered based on the coronavirus cases identified in each Grama Niladhari division, he noted.
Meanwhile, during a virtual discussion between President Gotabaya Rajapaksa and World Health Organization’s Director-General Dr. Tedros Adhanom, it transpired that approval would be given in another 2-3 days for the China-made Sinopharm coronavirus vaccine to be used for emergency use.
The National Medicines Regulatory Authority (NMRA) approved the emergency use of Sinopharm COVID-19 vaccine in Sri Lanka on March 20. ....

Sri Lanka , Sri Lankans , Tedros Adhanom , Channa Jayasumana , Ada Derana , Gotabaya Rajapaksa , China National Biotec Group , China National Pharmaceutical Group Corporation , World Health Organization , Regulation Of Pharmaceuticals Prof , National Medicines Regulatory Authority , Courtesy Ada , State Minister , Grama Niladhari , President Gotabaya Rajapaksa , China Made Sinopharm , ஸ்ரீ லங்கா , சீனா தேசிய பயோடெக் குழு , சீனா தேசிய மருந்து குழு நிறுவனம் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , ஒழுங்குமுறை ஆஃப் மருந்துகள் ப்ரொஃப் , தேசிய மருந்துகள் ஒழுங்குமுறை அதிகாரம் , மரியாதை அடா , நிலை அமைச்சர் ,

SA wants Chinese and Russian vaccines for 10 million people – but regulators say not yet


SA wants Chinese and Russian vaccines for 10 million people – but regulators say not yet
 Apr 30, 2021, 07:02 AM
facebook
email
Ampoules with the Gam-COVID-Vac (Sputnik V) vaccine at a mobile Covid-19 vaccination site outside the Viktoria shopping center. (Photo by Vitaly NevarTASS via Getty Images)
Covid-19 vaccines developed in China and Russia could be introduced in South Africa if they get approval from the Health Products Regulatory Authority.
Health minister Zweli Mkhize confirmed government’s intention to acquire enough of Russia’s Sputnik V and China’s Sinovac doses to vaccinate 10 million people.
But both vaccines have shown diminished efficacy in combatting Covid-19 variants, particularly 501Y.V2. ....

South Africa , South Africans , Africa Covid , Zweli Mkhize , Sinovac Coronavac , Vitaly Nevar , Boitumelo Semete Makokotlela , Sinovac Biotech , China National Pharmaceutical Group Corporation , Thailand Department Of Disease , Russian Direct Investment Fund , World Health Organisation , Gamaleya Research Institute Of Epidemiology , Africa Health Products Regulatory Authority Sahpra , Health Products Regulatory Authority , Getty Images , Health Products Regulatory , Gamaleya Research Institute , World Health , Disease Control , சீனா தேசிய மருந்து குழு நிறுவனம் , தாய்லாந்து துறை ஆஃப் நோய் , ரஷ்ய நேரடி முதலீடு நிதி , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , ஆரோக்கியம் ப்ராடக்ட்ஸ் ஒழுங்குமுறை அதிகாரம் , கெட்டி படங்கள் ,